Clinical Trial Update: Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing switching to rosuvastatin, adding ezetimibe to atorvastatin, or doubling the dose of atorvastatin in patients with hypercholesterolemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Atherosclerosis | Phase 4 | Status: TERMINATED